Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsArtificial IntelligenceDiagnostics AI

PUBLISHER: Grand View Research | PRODUCT CODE: 1941795

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1941795

Artificial Intelligence In Diagnostics Market Size, Share & Trends Analysis Report By Component, By Diagnosis Type, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Artificial Intelligence In Diagnostics Market Summary

The global artificial intelligence in diagnostics market size was estimated at USD 1.97 billion in 2025 and is projected to reach USD 9.68 billion by 2033, growing at a CAGR of 21.74% from 2026 to 2033. Market growth is driven by advancements in machine learning and deep learning, enabling faster, more accurate diagnostic solutions.

In oncology, cardiology, and neurology, among the areas, the growing demand for early disease detection has led to increased adoption of AI technologies. For instance, in February 2024, Royal Philips introduced the Philips CT 5300, an advanced AI-powered CT system designed for diagnostics, interventional procedures, and screenings. The adaptable X-ray CT system enhances diagnostic accuracy, streamlines workflows, and optimizes system availability.

Rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular disorders, etc., coupled with the increasing demand for early & accurate diagnosis, are significant factors driving market growth. The increasing incidence of cancer globally has led to a growing dependence on AI in the field of oncology. According to the NIH estimates of 2023, approximately 2.0 million individuals in the U.S. are diagnosed with cancer. Breast cancer was the most diagnosed cancer, with an estimated 297,790 cases in women and 2,800 cases in men. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths.

Such a high prevalence increases the diagnostic workload. Advancements in healthcare IT infrastructure and ongoing technological developments in cloud storage, computing, and machine learning algorithms support the integration of AI-powered systems into diagnostics to provide efficient & accurate diagnoses, allowing care providers to devise timely & appropriate treatment plans. Pathology and radiology services are witnessing a widespread adoption of AI-based algorithms. For instance, in January 2026, Alpenglow Biosciences and PathNet formed a strategic partnership to develop and commercialize 3D AI diagnostic tests for prostate and bladder cancer. The collaboration advances urologic oncology from 2D to 3D pathology in the U.S., integrating imaging, AI analytics, and workflows for enhanced accuracy.

"PathNet's leadership in urologic oncology, digitization, AI, and strong national footprint make them an exceptional partner as we bring clinical 3D pathology to market. Together, we are building diagnostic tools that deliver insights not achievable with conventional 2D histology."

Dr. Nicholas Reder, CEO of Alpenglow Biosciences

In addition, several AI-powered tools are used to diagnose chronic kidney disease (CKD) & kidney function tests, and various chronic diseases. For instance, in May 2024, Premier, Inc. partnered with AstraZeneca to launch the Uncover CKD - Care Collective initiative. The aim is to identify patients with undiagnosed CKD, raise awareness among healthcare providers, and assist U.S. health systems in improving their CKD diagnosis, treatment, and management. Leveraging Premier's PINC AI technology and services platform, the initiative seeks to address the increasing prevalence of undiagnosed CKD and its associated economic burden on the U.S. healthcare system.

Global Artificial Intelligence In Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial intelligence in diagnostics market report based on component, diagnosis type, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Services
  • Diagnosis Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest and Lung
  • Neurology
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68038-871-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. Diagnosis type
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. Diagnosis type outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Artificial Intelligence In Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Artificial Intelligence In Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
  • 3.4. Case Study Insights

Chapter 4. Artificial Intelligence In Diagnostics Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Artificial Intelligence In Diagnostics Market, By Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence In Diagnostics Market: Diagnosis Type Estimates & Trend Analysis

  • 5.1. Diagnosis Type Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Artificial Intelligence In Diagnostics Market, By Diagnosis Type Outlook
  • 5.4. Cardiology
    • 5.4.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.6. Pathology
    • 5.6.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.7. Radiology
    • 5.7.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.8. Chest and Lung
    • 5.8.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.9. Neurology
    • 5.9.1. Market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence In Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Diagnosis Type

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Competitor Growth Readiness Index (GRI), 2025
  • 7.2. Competitor Capability Matrix, 2025
  • 7.3. Company Categorization
  • 7.4. Company Market Position Analysis
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles/Listing
    • 7.6.1. Key company market share analysis, 2025
    • 7.6.2. Siemens Healthineers
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Zebra Technologies Corp.
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Riverain Technologies
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Vuno, Inc.
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Aidoc
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. NovaSignal Corporation (previously known as Neural Analytics, acquired by NeuraSignal, Inc.)
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Koninklijke Philips N.V.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Digital Diagnostics, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
    • 7.6.10. GE Healthcare
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives
    • 7.6.11. AliveCor Inc.
      • 7.6.11.1. Company overview
      • 7.6.11.2. Financial performance
      • 7.6.11.3. Product benchmarking
      • 7.6.11.4. Strategic initiatives
    • 7.6.12. F. Hoffmann-La Roche Ltd
      • 7.6.12.1. Company overview
      • 7.6.12.2. Financial performance
      • 7.6.12.3. Product benchmarking
      • 7.6.12.4. Strategic initiatives
Show more
Product Code: GVR-4-68038-871-8

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 4. Global AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 5. North America AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 6. North America AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 7. North America AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 8. U.S. AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 9. U.S. AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 10. Canada AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 11. Canada AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 12. Mexico AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 13. Mexico AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 14. Europe AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 15. Europe AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 16. Europe AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 17. UK AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 18. UK AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 19. Germany AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 20. Germany AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 21. France AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 22. France AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 23. Italy AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 24. Italy AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 25. Spain AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 26. Spain AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 27. Norway AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 28. Norway AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 29. Denmark AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 30. Denmark AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 31. Sweden AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 32. Sweden AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 33. Asia Pacific AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 36. Japan AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 37. Japan AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 38. China AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 39. China AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 40. India AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 41. India AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 42. Australia AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 43. Australia AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 44. South Korea AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 45. South Korea AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 46. Thiland AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 47. Thailand AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 48. Latin America AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 49. Latin America AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 50. Latin America AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 51. Brazil AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 52. Brazil AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 53. Argentina AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 54. Argentina AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 55. Middle East & Africa AI in diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 58. South Africa AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 59. South Africa AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 60. Saudi Arabia AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 62. UAE AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 63. UAE AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)
  • Table 64. Kuwait AI in diagnostics market, by component, 2021 - 2033 (USD Million)
  • Table 65. Kuwait AI in diagnostics market, by diagnosis type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 PESTLE analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 AI in diagnostics market: Component outlook and key takeaways
  • Fig. 15 AI in diagnostics market: Component movement analysis
  • Fig. 16 Software market, 2021 - 2033 (USD Million)
  • Fig. 17 Hardware market, 2021 - 2033 (USD Million)
  • Fig. 18 Services market, 2021 - 2033 (USD Million)
  • Fig. 19 AI in diagnostics market: Diagnosis type outlook and key takeaways
  • Fig. 20 AI in diagnostics market: Diagnosis type movement analysis
  • Fig. 21 Cardiology market, 2021 - 2033 (USD Million)
  • Fig. 22 Oncology market, 2021 - 2033 (USD Million)
  • Fig. 23 Pathology market, 2021 - 2033 (USD Million)
  • Fig. 24 Radiology market, 2021 - 2033 (USD Million)
  • Fig. 25 Chest and lung market, 2021 - 2033 (USD Million)
  • Fig. 26 Neurology market, 2021 - 2033 (USD Million)
  • Fig. 27 Others market, 2021 - 2033 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2025 & 2033
  • Fig. 30 AI in diagnostics market: Region movement analysis
  • Fig. 31 North America AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 32 US AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Europe AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 39 UK AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Germany AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Norway AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamic
  • Fig. 53 Sweden AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Asia Pacific AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Japan AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Latin America AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 69 Brazil AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Middle East and Africa AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 74 South Africa AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait AI in diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Company categorization
  • Fig. 83 Strategy mapping
  • Fig. 84 Company market position analysis
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!